Asianet NewsableAsianet Newsable
77 results for "

Bharat Biotech

"
Covaxin shows only 50% efficacy against symptomatic COVID-19: Lancet Study-dnmCovaxin shows only 50% efficacy against symptomatic COVID-19: Lancet Study-dnm

Covaxin shows only 50% efficacy against symptomatic COVID-19: Lancet Study

The latest Covaxin data may dent its appeal at a time when Bharat Biotech is ramping up production while studies show that most vaccines have reduced efficacy against the Delta variant.

Top Stories Nov 24, 2021, 5:40 PM IST

Bharat Biotech's Covaxin 'highly efficacious' with 77.8% efficacy against all COVID variants-dnmBharat Biotech's Covaxin 'highly efficacious' with 77.8% efficacy against all COVID variants-dnm

Bharat Biotech's Covaxin ‘highly efficacious’ with 77.8% efficacy against all COVID variants

Covaxin, which uses traditional, inactivated-virus technology, "induces a robust antibody response" two weeks after two doses are given, The Lancet said in a statement.

Top Stories Nov 12, 2021, 10:31 AM IST

Bharat Biotech CMD Krishna Ella speaks on booster dose after 6 months of 2nd Covaxin shot-dnmBharat Biotech CMD Krishna Ella speaks on booster dose after 6 months of 2nd Covaxin shot-dnm

Bharat Biotech CMD Krishna Ella speaks on booster dose after 6 months of 2nd Covaxin shot

Ella was speaking at the Times Now Summit 2021, where he talked about the nasal vaccine being developed by Bharat Biotech after its Covaxin, he said that the Phase 2 trials are done and data was being analysed.

Top Stories Nov 11, 2021, 9:51 AM IST

UK to recognise India's indigenous COVID vaccine Covaxin, to add to approved list from November 22-dnmUK to recognise India's indigenous COVID vaccine Covaxin, to add to approved list from November 22-dnm

UK to recognise India’s indigenous COVID vaccine Covaxin, to add to approved list from November 22

This means that those inoculated with the Bharat Biotech-manufactured jab will not have to undergo self-isolation after arrival in England.
 

World News Nov 9, 2021, 12:24 PM IST

Bharat Biotech's COVID-19 vaccine Covaxin gets shelf life extension to 12 months-dnmBharat Biotech's COVID-19 vaccine Covaxin gets shelf life extension to 12 months-dnm

Bharat Biotech’s COVID-19 vaccine Covaxin gets shelf life extension to 12 months

Bharat Biotech in a statement on Wednesday said that this approval is based on the availability of additional stability data, which was submitted to CDSCO.
 

Top Stories Nov 3, 2021, 5:52 PM IST

World Health Organisation accepts Bharat Biotech's Covaxin for emergency use gcwWorld Health Organisation accepts Bharat Biotech's Covaxin for emergency use gcw

WHO accepts Bharat Biotech's Covaxin for emergency use listing

Covaxin has shown 77.8 percent efficacy against symptomatic Covid-19 and 65.2% protection against the novel Delta variant.

Top Stories Nov 3, 2021, 5:35 PM IST

Guyana approves Made-in-India vaccine Covaxin, to allow vaccinated travellers to enter country gcwGuyana approves Made-in-India vaccine Covaxin, to allow vaccinated travellers to enter country gcw

Guyana approves Made-in-India vaccine Covaxin, to allow vaccinated travellers to enter country

In a statement, the Guyanese health ministry listed out the vaccines approved for the travellers who wish to visit the country. 
 

India News Nov 2, 2021, 1:27 PM IST

WHO seeks additional clarifications from Bharat Biotech to approve Covaxin-dnmWHO seeks additional clarifications from Bharat Biotech to approve Covaxin-dnm

WHO seeks ‘additional clarifications’ from Bharat Biotech to approve Covaxin

Bharat Biotech has been submitting data to WHO on a rolling basis and submitted additional information at the UN health body's request on September 27.

Top Stories Oct 27, 2021, 9:16 AM IST

WHO advisory group on Covaxin's emergency use approval says Expect recommendation within next 24 hours gcwWHO advisory group on Covaxin's emergency use approval says Expect recommendation within next 24 hours gcw

'Expect recommendation within next 24 hours or so': WHO advisory group on Covaxin's emergency use approval

Millions of Indians have received the Bharat Biotech vaccine, yet many have been unable to travel due to the WHO's permission.

World News Oct 26, 2021, 7:00 PM IST

As India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today-dnmAs India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today-dnm

As India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today

The officials confirmed that representatives from seven vaccine makers including Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech will be participating in the meeting.
 

Top Stories Oct 23, 2021, 11:35 AM IST

Extremely essential often takes longer Top WHO official on approval of emergency use of Covaxin gcwExtremely essential often takes longer Top WHO official on approval of emergency use of Covaxin gcw

'Extremely essential, often takes longer': Top WHO official on approval of emergency use of Covaxin

Dr Ryan was replying to a query about if there would be a final response on Covaxin Emergency Use Listing by October 26 at a recent virtual Q&A.

World News Oct 22, 2021, 3:58 PM IST

WHO expects additional information from Bharat Biotech before recommending Covaxin, says 'Cannot cut corners'-dnmWHO expects additional information from Bharat Biotech before recommending Covaxin, says 'Cannot cut corners'-dnm

WHO expects additional information from Bharat Biotech before recommending Covaxin, says 'Cannot cut corners'

Bharat Biotech has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data.

Top Stories Oct 18, 2021, 7:34 PM IST

Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech-dnmAwaiting regulatory approvals to launch Covaxin for children: Bharat Biotech-dnm

Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech

The recommendations have been forwarded to the Drugs Controller General of India (DCGI) for final approval.

Top Stories Oct 12, 2021, 5:50 PM IST

Covaxin gets approval for children between 2-18 years-dnmCovaxin gets approval for children between 2-18 years-dnm

Covaxin gets approval for children between 2-18 years

The Subject Expert Committee on Covid-19 approved emergency use approval to Bharat Biotech's Covaxin for children between 2-18 years.

Top Stories Oct 12, 2021, 1:26 PM IST

Bharat Biotech in partnership with GSK to produce world's 1st malaria vaccine approved by WHO-dnmBharat Biotech in partnership with GSK to produce world's 1st malaria vaccine approved by WHO-dnm

Bharat Biotech in partnership with GSK to produce world's 1st malaria vaccine approved by WHO

Spent over 30 years developing and testing the world's first malaria vaccine, Bharat Biotech is the global technology transfer recipient from GlaxoSmithKline (GSK).

Top Stories Oct 8, 2021, 9:37 AM IST